| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |